Gabapentin Tablet
Product Images NDC 63629-8489

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain scores over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks with a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain score over a 7-week period comparing placebo and gabapentin at doses of 1800 mg/day and 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain scores from 0 to 10.*

FDA Label Image

Figure 3 (Image 03)

Bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' from two studies. The vertical axis shows percentage responders from 0% to 100%. Study 1 compares placebo (PBO) at 12% and Gabapentin (GBP) 3600 mg at 29%. Study 2 compares placebo (PBO) at 14%, GBP 1800 mg at 32%, and GBP 2400 mg at 34%. Statistical significance is noted with p-values less than 0.01 and 0.001.*

FDA Label Image

Image-04 (Image 04)

An illustration showing the Cockcroft-Gault equation for estimated creatinine clearance (CLCr) calculation. The formula includes variables for age (years), weight (kg), serum creatinine (mg/dL), and a multiplication factor of 0.85 for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin, showing a cyclohexane ring attached to a side chain with amine (CH2NH2) and carboxyl (CH2CO2H) functional groups.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing the percentage difference on the vertical axis versus daily dose in mg on the horizontal axis for Gabapentin. It displays data points from three studies labeled a, b, and c, with doses ranging roughly from 600 mg to 1800 mg. The chart compares differences across these doses for the three study groups.*

FDA Label Image

Label (Lbl636298489)

Gabapentin Tablets, USP 800 mg oral tablet label with NDC 63629-8489-01. The label states it is manufactured by Sciegen Pharmaceuticals and relabeled by Bryant Ranch Prepack. Contains 500 tablets. Includes storage instructions and a child-resistant closure notice. Features barcode and BRP Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.